L stock · ORMP stock

L vs ORMP

Loews Corp (L) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.

Loews Corp (L) is a insurance - property & casualty company listed on NYSE.

Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.

Latest reported L revenue for 2024-12-31 was $17.51B. Net income was $1.49B. Revenue was up 10.1% from 2023-12-31 to 2024-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.

Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.

L currently screens at market cap $22.36B and trailing P/E 13.8. ORMP currently screens at market cap $87.2M.

Not investment advice. Open the L and ORMP stock pages for the full models.

Not investment advice.

Popular Stock Comparisons